Effects of genetic variation in the novel organic cation transporter, OCTN1, on the renal clearance of gabapentin. Read more about Effects of genetic variation in the novel organic cation transporter, OCTN1, on the renal clearance of gabapentin.
Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics. Read more about Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics.
Identification of novel CYP2A6*1B variants: the CYP2A6*1B allele is associated with faster in vivo nicotine metabolism. Read more about Identification of novel CYP2A6*1B variants: the CYP2A6*1B allele is associated with faster in vivo nicotine metabolism.
Vaporization as a smokeless cannabis delivery system: a pilot study. Read more about Vaporization as a smokeless cannabis delivery system: a pilot study.
Amodiaquine metabolism is impaired by common polymorphisms in CYP2C8: implications for malaria treatment in Africa. Read more about Amodiaquine metabolism is impaired by common polymorphisms in CYP2C8: implications for malaria treatment in Africa.
The pharmacogenetics research network: from SNP discovery to clinical drug response. Read more about The pharmacogenetics research network: from SNP discovery to clinical drug response.
ABCB1 pharmacogenetics: progress, pitfalls, and promise. Read more about ABCB1 pharmacogenetics: progress, pitfalls, and promise.
Irinotecan-induced diarrhea: functional significance of the polymorphic ABCC2 transporter protein. Read more about Irinotecan-induced diarrhea: functional significance of the polymorphic ABCC2 transporter protein.
Nicotine intake and dose response when smoking reduced-nicotine content cigarettes. Read more about Nicotine intake and dose response when smoking reduced-nicotine content cigarettes.
Effect of grapefruit juice on cytochrome P450 2A6 and nicotine renal clearance. Read more about Effect of grapefruit juice on cytochrome P450 2A6 and nicotine renal clearance.